Navigation Links
Cogentus to Launch Phase III Program of Novel Combination Product Designed to Reduce Bleeding Side Effect of Antiplatelet Therapy
Date:11/15/2007

COGENT Trials To Enroll 4,000 Patients Worldwide

MENLO PARK, Calif., Nov. 15 /PRNewswire/ -- Cogentus Pharmaceuticals, Inc. announced today it is launching a global Phase III clinical program to evaluate the efficacy and safety of its novel combination therapy CGT-2168. The program, which includes the COGENT-1 and COGENT-2 trials, will enroll over 4,000 patients at hundreds of sites in the United States, Canada, Europe and South America.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071112/COGENTUSLOGO)

CGT-2168 is a unique once-daily pill that combines the antiplatelet agent clopidogrel (currently marketed by Bristol-Myers Squibb Co. and Sanofi-Aventis as Plavix(R)) with a gastroprotectant (omeprazole). The product is designed to significantly reduce the gastrointestinal side effects commonly associated with antiplatelet therapy.

COGENT stands for the Clopidogrel and the Optimization of Gastrointestinal Events Trial. The COGENT trials are designed to measure the incidence of upper gastrointestinal bleeding and ulcers in patients who take CGT-2168 and aspirin compared with patients who take clopidogrel and aspirin. The vast majority of patients who take clopidogrel also take aspirin.

Antiplatelet therapy is an integral part of treating patients with cardiovascular disease, including acute coronary syndrome, and has been shown to be effective in preventing major cardiovascular events. However, treatment with antiplatelet medicines such as clopidogrel, aspirin or the frequent combination of the two is associated with gastrointestinal bleeding, which in some cases can require hospitalization and even result in death.

"The benefits of antiplatelet therapy are well established, but the risk of bleeding associated with these treatments has been greatly under-appreciated," said Kim Fox, M.D., F.R.C.P., Director of Cardiology at Royal Br
'/>"/>

SOURCE Cogentus Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
4. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
5. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
6. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
7. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
8. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
9. Premier Micronutrient Launches Supplement for Hearing Health
10. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
11. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... MOUNTAIN VIEW, Calif. , Aug. 31, ... EURONEXT: SAN) and the life sciences team at Google ... and outcomes for people with type 1 and type ... and devices with Google,s expertise in analytics, miniaturized electronics ... how to improve diabetes care by developing new tools ...
(Date:8/31/2015)...  AMRI (NASDAQ: AMRI ) and Saneca ... on the development, manufacture and marketing of a ... collaboration combines Saneca,s strength in extracting opiates from ... manufacturing controlled substance APIs with AMRI,s U.S. assets ... these facilities. The collaboration will also capitalize on ...
(Date:8/31/2015)... Vascular Ltd., together with its subsidiaries (the "Company" ... the "Group"), a global company engaged in the ... for the minimally invasive treatment of vascular disease, ... ("BTK") cohort of patients in the Chocolate® Balloon ... 15, 2015 at the 5th Annual Amputation Prevention ...
Breaking Medicine Technology:Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4
... Communicating effectively oftentimes goes beyond words. Facial expressions ... joy, excitement, or even acceptance and approval through ... discolored and uneven teeth hold you back from ... allows dentists to help patients increase their communication ...
... DIEGO, Aug. 3, 2011 Proacta Incorporated and ... the expansion of their Collaborative Research, Development and ... a hypoxia-activated pro-drug for the treatment of cancer. ... parties agreed to expand their existing collaboration to ...
Cached Medicine Technology:A Beautiful Smile Enhances Communication Skills 2Proacta Incorporated and Yakult Honsha Announce Expansion of Their Collaborative Research, Development and Commercialization Agreement 2Proacta Incorporated and Yakult Honsha Announce Expansion of Their Collaborative Research, Development and Commercialization Agreement 3
(Date:8/31/2015)... ... August 31, 2015 , ... ITC Global Translations website, ... for specific translation services within the medical and pharmaceutical industries. These are industries ... successful work. , ITC Global Translations specializes in professional translation services for materials ...
(Date:8/31/2015)... Angeles, CA (PRWEB) , ... August 31, 2015 , ... ... 16 by CDA Press, the expert guest author addressed the topic of treating back ... author explained that, while steroids were shown to slightly improve physical function in patients ...
(Date:8/31/2015)... ... August 31, 2015 , ... Women’s Excellence in Wellness, ... to the Lake Orion area. This program is one of the most successful ... management program will incorporate group fitness and nutritional consultations to help people lose ...
(Date:8/31/2015)... ... August 31, 2015 , ... Patients who thought about getting a hair transplant ... learning more about the procedure beyond the information found on the Internet can attend ... surgeon Parsa Mohebi will be on hand to answer patients hair transplant questions at ...
(Date:8/31/2015)... , ... August 31, 2015 , ... In an ... the Plastic and Reconstructive Surgery Global Open Journal that discusses the future of 3-D ... discussed how, in the future, customized implants, prosthetics, and other 3-D printed tools could ...
Breaking Medicine News(10 mins):Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3Health News:Article on Steroid Use for Back Pain Highlights the Effectiveness of Surgery in Treating Disk Pain, says Dr. Seyed M. Rezaian 2Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3
... Indian Systems of Medicine and the government was now preparing a ... , state Health Minister K K S S R Ramachandran, said ... an Ayurveda college and would take all efforts in this direction, ... the All India Ayurvedic Congress (AIAC) as part of its centenary., ...
... ever-private fertility clinic has been established by two leading ... around the ages of 45 with the// treatment. ... and a leading authority in the field of IVF, ... is qualified to carry out pre-implantation genetic diagnosis that ...
... has yet again been honored with the Magnet status, ... to be the highest recognition for nursing services signifying ... second time that Rush University has received this much-coveted ... the United States have received Magnet designation twice. ...
... Jackson and Fran Walsh’s donation of $500,000 to the University ... well in their home// country. Citing that stem cell research ... hoped the donation could be put to good use. ... Parkinson's disease, and the level of personal suffering inflicted on ...
... babies born in the United States are screened for ... the March of Dimes and the American Academy of ... of Medical Genetics calling for expanded screening for 29 ... and child health expert Russell Kirby, Ph.D., agrees. “All ...
... are taking due precaution following reports of suspected dengue ... with the blood sample// of the affected being sent ... has shown symptoms of Dengue fever and we have ... awaiting the reports," KDMC run Municipal hospital doctor Sanjeev ...
Cached Medicine News:Health News:Scotland's First 'Stand-Alone' Private Fertility Centre Established 2Health News:Scotland's First 'Stand-Alone' Private Fertility Centre Established 3Health News:Scotland's First 'Stand-Alone' Private Fertility Centre Established 4Health News:Rush of honor for Rush University – Magnet Status for Excellence in Nursin 2
... 300A is a portable, digital A-scan system ... combination of a high frequency, low noise ... capture immediately upon application of the probe ... provides: live A-scan display, storage of 5 ...
... Echoscan US-800 Ultrasonic A-Scan offers ... compact, portable package. Besides,its compact ... highly accurate measurement and easy ... automatic freezing and manual gate.,NIDEK ...
... first very high frequency digital ultrasound eye ... provides microscopic resolution images and precision measurement ... of the human eye. Artemis is a ... In use, the patient leans forward placing ...
ISYSTEM-ABDv2™A/B Scan unit. True Geometry With Stepped Zoom, Pan, Freeze Frame, Post Image Processing....
Medicine Products: